This research analyzes trends and revenue in the global emerging interventional cardiac devices market from 2010 to 2020, with a base year of 2013 and a forecast from 2014 to 2020. The market is divided into 5 segment modalities, including transcatheter heart valves, renal denervation, bronchial thermoplasty, bioresorbable stents, and fractional flow reserve. The geographic scope covers the United States, Europe, and Rest of World (ROW). Trends evaluated include forecast trends, challenges and opportunities, country snapshots, and key findings. Key competitor market shares are also estimated for 2013. A competitive playbook and competitive analysis are provided, and 3 big predictions close the study.